Orbis Medicines (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 20, 2025
- Vertical
- Pharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $90,000,000
Company Info
- Traction
- Total amount raised by the company to date is EUR 116 million.
- Company Description
- Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.
- Market
- Oral macrocycle drugs
- Location
- Epalinges, Switzerland
- Coinvestors
- NEA, Eli Lilly and Company, Cormorant, Export and Investment Fund of Denmark, Novo Holdings, Forbion